Category Archives: Dangerous Drugs

May 24, 2010 … If you are one of the millions of Americans who are injured or killed every year by dangerous prescription drugs, you need to read our verdicts and settlements, file a case …

Indian Drug Maker Recalling Antibacterial Drug

The U.S. unit of Lupin Ltd., an Indian drug maker, is recalling thousands of bottles of antibacterial drugs, due to a failure to meet the FDA standards for impurities. The recall, reported by the Wall Street Journal, was initiated on Jan. 27, but the FDA did not notify the public until the week of April 14.

This recall is for a drug called cefixime, which is an antibiotic used to treat bacterial infections of the upper-respiratory tract and of the ear. The FDA considers this a Class III recall, according to Reuters, meaning that use of or exposure to the drug is unlikely to cause adverse health effects.

Cohen Placitella & Roth PC has distinguished itself as proven leaders in product liability and consumer protection litigation, and has won multi-million dollar recoveries in a variety of these suits. We invite you to contact Chris Placitella, Esq. today for a consultation at 888-375-7600 to discuss your case.

America Needs Your Help to Make Generic Drugs Safe

If you are injured or killed by a defective generic drug under the current state of the law you have NO RIGHT TO COMPENSATION.  There is currently a proposal before the FDA  that would change all that. Your help is needed and America needs you to act NOW. The comment period ends tomorrow, Thursday the 13th at 11:59 pm.  Comments canContinue Reading

$7.25 Million Awarded in Cochlear Device Suit

A U.S. District Court has awarded $7.25 million to a Louisville girl who was severely shocked by a cochlear device implanted in her head. The lawsuit claimed that the device, manufactured by Advance Bionics, was defective and that company executives were aware of the defects and hid that fact from consumers. The suit stated thatContinue Reading


  A Johnson & Johnson subsidiary agreed Thursday to pay $181 million to settle dozens of states' claims that it engaged in illegal off-label marketing of antipsychotic drugs, with New Jersey to receive $5.3 million. Janssen Pharmaceuticals Inc. of Titusville improperly marketed Risperdal, Risperdal Consta, Risperdal M-Tab and Invega, in violation of federal law, accordingContinue Reading

Former sales rep files false-marketing suit against Abbott.

The Chicago Tribune (8/22, Frost) reports that a former Abbott Laboratories sales representative “filed a federal lawsuit against the company, accusing it of illegally promoting its cholesterol drug” TriCor (fenofibrate) for uses not approved by the FDA, including the “prevention of cardiac risks in patients with diabetes.” The False Claims lawsuit, “filed in the USContinue Reading